Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Stat Med. 2021 Nov 20;40(26):5796-5812. doi: 10.1002/sim.9155. Epub 2021 Aug 2.
Dynamic treatment regimes (DTRs), consisting of a sequence of tailored treatment decision rules that span multiple stages of care, present a unique opportunity in our drive toward personalized medicine. Given that estimation of optimal DTRs is often exploratory and communication with clinicians is vital, robust and flexible methods that yield interpretable results are needed. Tree-based methods utilizing a purity measure defined on the full set of covariates have enjoyed much success in meeting this goal. Often, however, it is necessary for clinical, practical, or ethical reasons to restrict certain covariates that should be used when making treatment decisions. Herein we present restricted sub-tree learning (ReST-L), a flexible and robust, sub-tree-based method to estimate an optimal multi-stage multi-treatment DTR that enables restrictions to the set of prespecified candidate tailoring variables. ReST-L employs a purity measure derived from an augmented inverse probability weighted estimator for the counterfactual mean outcome, using observational data to build multi-stage decision trees that are restricted in sub-tree spaces defined by the corresponding prescriptive covariates. We show that ReST-L is able to correctly estimate the optimal DTR searching over a large number of variables with relatively small sample sizes and improves upon competing estimation methods. We demonstrate the utility of ReST-L to estimate a two-stage fluid resuscitation strategy for patients admitted to an intensive care unit with acute emergent sepsis.
动态治疗方案(DTRs)由一系列针对多个治疗阶段的定制治疗决策规则组成,为我们向个性化医疗迈进提供了独特的机会。由于最优 DTR 的估计通常是探索性的,与临床医生的沟通至关重要,因此需要使用能够产生可解释结果的强大而灵活的方法。基于树的方法利用在整个协变量集上定义的纯度度量在满足这一目标方面取得了很大的成功。然而,出于临床、实际或伦理原因,通常需要限制在做出治疗决策时应使用的某些协变量。本文提出了受限子树学习(ReST-L),这是一种灵活且强大的基于子树的方法,用于估计最优的多阶段多治疗 DTR,允许限制指定的候选定制变量集。ReST-L 使用从增强逆概率加权估计器得出的纯度度量来估计反事实的平均结果,使用观察数据构建受限的子树空间,这些空间由相应的规范协变量定义。我们表明,ReST-L 能够在相对较小的样本量下正确估计最优 DTR,同时也优于竞争的估计方法。我们展示了 ReST-L 在估计 ICU 中急性紧急败血症患者的两阶段液体复苏策略方面的实用性。